Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram- negative bacteria

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 6, 1996, Pages 728-732

  Blanco, A ^a,d   Solis, G ^b   Arranz, E ^a   Coto, G D ^c   Ramos, A ^c   Telleria, J ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b Hospital of Cabueñes   (France)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; FIBRONECTIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; IMMUNODIFFUSION; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL;

EID: 0029810162     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14135.x     Document Type: Article

References (27)

1. Clemente F, Tapia C, Escriva P, Rubio A, Garcia R, Jiménez B. Sepsis neonatal: Incidencia y factores de riesgo. An Esp Pediatr 1992;37:481-3
2. Quie PG. Antimicrobial defenses in the neonate. Semin Perinatol 1990;14(Suppl 1):2-9
3. Hack CE, de Groot ER, Felt-Bersma RJF, Nuyens JF, Strack van Schijndel RJM, Eerenberg-Belmer AJM, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10
4. Whicher JT, Evans SW. Cytokines in diseases. Clin Chem 1990;36:1269-81
5. Helminen M, Vesikari T. Increased interleukin-1 (IL-1) production from LPS-stimulated peripheral blood monocytes in children with febrile convulsions. Acta Paediatr Scand 1990;79:810-6
6. van Deventer SJH, Buller HR, Cate TJW, Aarden LA, Hack CE, Stark A. Experimental endotoxemia in human analysis of cytokine release and coagulation. Blood 1990;76:2520-6
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3
8. Jabara HH, Vercelli D. Engagement of CD14 on monocytes inhibits the synthesis of human Igs, includina IgE. J Immunol 1994;53:972-8
9. Lynn WA, Liu Y, Golenbock DT. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect Immun 1993;61:4452-61
10. Kruger C, Schutt C, Obertacke U, Joka T, Muller FE, Knoller J, et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991;85:297-301
11. Homolka J, Lorenz J, Zuchold HD, Mullerquernheim J. Evaluation of soluble CD-14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin Invest 1992;70: 10;909-16
12. Wuthrich B, Kagi MK, Jollerjemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992;284:339-42
13. Horneff G, Sack U, Kalden JR, Emmrich F, Burmester GR. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment - decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993;91:207-13
14. Nockher WA, Wigan R, Schoeppe W, Scherberich JE. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin Exp Immunol 1994;96:15-9
15. Martin TR, Rubenfeld G, Steinberg KP, Hudson LD, Raghu G, Moriarty AM, et al. Endotoxin, endotoxin-binding protein, and soluble CD14 are present in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Chest 1994;105:S55-6
16. Frey EA, Miller DS, Jahr TG, Sundan A, Bazil Y, Espevik T, et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992;176:1665-71
17. Pugin J, Schurermaly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90: 2744-8
18. Arditi M, Zhou J, Dorio R, Rong GW, Coyert SM, Kim KS. Endotoxin-mediated endothelial cell injury and activation - role of soluble CD14. Infect immunol 1993;61:3149-56
19. Haziot A, Rong GW, Silver J, Goyert SM. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 1993;151:1500-7
20. Grunwald U, Kruger C, Schutt C. Endotoxin-neutralizing capacity of soluble CD14 is highly conserved specific function. Circ Shock 1993;39:220-5
21. Kessler A, Grunert C, Wood WG. The limitations and usefulness of C-reactive protein and elastase-α(1)-proteinase inhibitor complexes as analytes in the diagnosis and follow-up of sepsis in newborns and adults. Eur J Clin Chem Clin Biochem 1994;32: 365-8
22. Tiao G, Rafferty J, Ogle C, Fischer JE, Hasselgren PO. Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 1994;116:332-8
23. Mustafa MM, Lebel MH, Ramilo O, Osen KD, Reisch JS, Beutler B, et al. Correlation of interleukin-1 beta and cachectin concentrations in cerebroespinal fluid and outcome from bacterial meningitis. J Pediatr 1989;115:208-13
24. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987:i:355-7
25. Sullivan JS, Kilpatrick L, Costarino AT, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 1992;120:510-5
26. Williams PA, Bohnsack JH, Augustine NH, Drummond WK, Rubens CE, Hill HR. Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr 1993;123:292-300
27. Sonderquist B, Sundqvist KG, Vikerfors T. Kinetics of serum levels of interleukin-6 in Staphylococcus-aureus septicaemia. Scand J Infect Dis 1992;24:607-12